DH vs. APPN, CXM, VNET, AVDX, EVCM, COUR, FORTY, PRCH, BBAI, and CERT
Should you be buying Definitive Healthcare stock or one of its competitors? The main competitors of Definitive Healthcare include Appian (APPN), Sprinklr (CXM), VNET Group (VNET), AvidXchange (AVDX), EverCommerce (EVCM), Coursera (COUR), Formula Systems (1985) (FORTY), Porch Group (PRCH), BigBear.ai (BBAI), and Certara (CERT). These companies are all part of the "computer software" industry.
Definitive Healthcare vs. Its Competitors
Definitive Healthcare (NASDAQ:DH) and Appian (NASDAQ:APPN) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.
Definitive Healthcare presently has a consensus price target of $4.73, suggesting a potential upside of 18.04%. Appian has a consensus price target of $33.40, suggesting a potential upside of 8.76%. Given Definitive Healthcare's higher possible upside, equities analysts plainly believe Definitive Healthcare is more favorable than Appian.
Appian has a net margin of -2.62% compared to Definitive Healthcare's net margin of -124.43%. Definitive Healthcare's return on equity of 3.94% beat Appian's return on equity.
98.7% of Definitive Healthcare shares are owned by institutional investors. Comparatively, 52.7% of Appian shares are owned by institutional investors. 16.3% of Definitive Healthcare shares are owned by company insiders. Comparatively, 43.0% of Appian shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Appian has higher revenue and earnings than Definitive Healthcare. Appian is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.
Definitive Healthcare has a beta of 1.64, meaning that its share price is 64% more volatile than the S&P 500. Comparatively, Appian has a beta of 1.75, meaning that its share price is 75% more volatile than the S&P 500.
In the previous week, Appian had 11 more articles in the media than Definitive Healthcare. MarketBeat recorded 14 mentions for Appian and 3 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 1.43 beat Appian's score of 0.99 indicating that Definitive Healthcare is being referred to more favorably in the media.
Summary
Appian beats Definitive Healthcare on 10 of the 16 factors compared between the two stocks.
Get Definitive Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for DH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding DH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Definitive Healthcare Competitors List
Related Companies and Tools
This page (NASDAQ:DH) was last updated on 8/29/2025 by MarketBeat.com Staff
MarketBeat All Access